“financing” Archives

in
Entry Author Date Location
Combined Therapeutics Inc Wins $250,000 MilliporeSigma Advance Biotech Grant 09/25/20 National
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies 08/26/20 San Francisco
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts 08/20/20 National
Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold 08/18/20 San Diego
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor 08/17/20 Boston
Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy 08/17/20 New York
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia 08/12/20 San Francisco
GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod 08/06/20 National
IgGenix Grabs $10M to Advance Antibody Treatments for Allergies 08/05/20 San Francisco
Novartis Pays $75M to Get Hands on Sangamo’s Zinc Fingers for Drug R&D 07/30/20 San Francisco
Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort 07/29/20 San Diego
Telehealth Firm AristaMD Adds $24M to Link Primary Docs With Specialists 07/27/20 San Diego
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire 07/21/20 San Francisco
MeiraGTx, J&J See Phase 3 Test Ahead for Vision Loss Gene Therapy 07/17/20 New York
After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test 07/14/20 San Diego
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases 07/01/20 Boston
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs 06/25/20 Boston
In Microbiome Milestone, Finch Therapeutics C. diff Pill Bests Placebo 06/19/20 Boston
Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs 06/18/20 San Diego
Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer 06/17/20 San Diego
Exec Search Underway at PacBio After CEO, CFO Announce Plans to Retire 06/16/20 San Francisco
Viela Bio Gets FDA Green Light for Rare Autoimmune Disease Treatment 06/12/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA 06/11/20 Texas
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Page 1 of 80 next page »